Connect With a Global Community of Experts
Over the next 10 years, the global dermatology therapeutics market is projected to double, soaring to $3.59bn in 2034, propelled forward by billion-dollar deals and strategic acquisitions highlight the sector’s accelerating growth, from inflammatory skin disease to aesthetic dermatology and rare conditions.
Leading pharma and biotech is doubling down on skin-focused innovation, with Gilead inking a $1.7 billion global inflammation deal with LEO Pharma, Organon’s $1.2 billion acquisition of Dermavant, while M&A activity in CDMO and imaging services continues to surge, like the Tergus-MedPharm merger and L’Oréal’s strategic stake in Galderma, reflect the full-spectrum opportunity for service providers across R&D and commercialization.
Top solutions needed:
Preclinical CROs:
Provide in vitro and in vivo dermatology models to assess safety, skin irritation, barrier function, and drug penetration. Key solutions include 3D human skin models, topical formulation screening, and disease-specific efficacy studies for indications like psoriasis, AD, and acne.
Clinical CROs:
Offer end-to-end trial management with dermatology expertise-site selection, dermatology-trained investigators, validated scoring systems (e.g., PASI, EASI), high-throughput photography, and patient recruitment for chronic and rare skin conditions.
Diagnostics & Imaging:
Deliver non-invasive imaging and digital tools for objective skin assessment. Solutions include confocal microscopy, dermoscopy, OCT, AI-based image analysis, and biomarker-driven diagnostics to track treatment response and support endpoint validation.
CDMOs:
Specialize in development and GMP manufacturing of topical, transdermal, and injectable dermatology products. Services include formulation optimization (creams, gels, ointments), scale-up, stability studies, and regulatory support.
Metabolomic & Proteomic Companies:
Enable biomarker discovery and mechanism-of-action studies via skin-specific omics profiling. Solutions include analysis of inflammatory cytokines, skin lipid metabolism, and protein expression changes in response to treatment.
Why Partner?
Showcase your solutions via a speaking slot or technology spotlight
Network 1:1 with decision-makers actively building pipelines in dermatology
Build long-term relationships with companies investing in novel skin-targeted therapies
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.